Overview A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer Status: Recruiting Trial end date: 2023-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to see if TAS0612 is safe in participants with advanced or metastatic solid tumor cancer. Phase: Phase 1 Details Lead Sponsor: Taiho Oncology, Inc.